Related Experiment Videos
[Chronic cardiac rejection. 20 anatomico-clinical cases]
Summary
Chronic cardiac rejection, a form of accelerated coronary disease after heart transplant, causes diffuse arterial lesions and thrombosis. This leads to painless ischemic heart failure, often underdiagnosed by angiography.
Area of Science:
- Cardiology
- Transplantation Immunology
- Pathology
Background:
- Chronic cardiac rejection is a major long-term complication following heart transplantation.
- Accelerated coronary artery disease (cardiac allograft vasculopathy) significantly impacts graft survival and patient outcomes.
- Understanding the anatomical and pathological features of this condition is crucial for diagnosis and management.
Purpose of the Study:
- To investigate the detailed anatomical and histopathological features of coronary lesions in chronic cardiac rejection.
- To correlate these findings with coronary angiographic appearances.
- To explore potential aetiopathological factors contributing to accelerated coronary disease post-transplant.
Main Methods:
- Anatomico-clinical study of 20 consecutive cases of chronic cardiac rejection after heart transplantation.
- Detailed histopathological analysis of coronary lesions, including epicardial and intramyocardial branches.
- Correlation of pathological findings with coronary angiographic images.
Main Results:
- Observed diffuse, circumferential atherosclerotic alterations with less individualized plaques than typical atherosclerosis.
- Frequent and multifocal thrombosis occurred in 50% of cases, leading to massive or disseminated myocardial ischemia.
- Painless ischemic cardiomyopathy due to denervation resulted in cardiac failure, necessitating retransplantation or leading to autopsy.
- Coronary angiography tended to underestimate the severity of coronary damage.
Conclusions:
- Chronic cardiac rejection manifests as a unique, diffuse coronary vasculopathy with frequent thrombosis.
- This condition leads to a restrictive ischemic cardiomyopathy and heart failure in heart transplant recipients.
- Immune-mediated arterial inflammation, viral infections, and platelet hyperactivity are suspected, but not definitively quantified, contributors.